News brief
On October 10, 2026, per 36Kr, AI-native peptide drug discovery platform Litai Zhiyao completed a near-¥50M seed round co-invested by iFlytek Ventures, L2F Fund and an unnamed industrial investor, for pipeline R&D, compute and patents.
Connected profiles
Explore
Sources · 1Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
- 36kr.com ↗Published Oct 10, 2026
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年10月10日，据36氪报道，AI原生多肽药物研发平台利太智药完成近5000万元人民币种子轮融资，由讯飞创投、L2F光源创业者基金及知名产业方联合投资。资金将用于核心管线研发、算力投入、专利布局与人才招募。